ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
The Impact of Demographic, Clinical, and Treatment Factors on Overall Survival in Ovarian Carcinosarcomas: A National Cancer Database Study
Provisionally accepted
- 1University of South Florida Morsani College of Medicine, Tampa, United States
- 2Arizona State University School of Life Sciences, Tempe, United States
- 3Creighton University School of Medicine - Phoenix Health Sciences Campus, Phoenix, United States
- 4East Carolina University Department of Obstetrics and Gynecology, Greenville, United States
- 5Creighton University Department of Medicine, Omaha, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Ovarian carcinosarcoma is a rare and highly aggressive biphasic neoplasm, accounting for less than 1% of ovarian malignancies. This study utilizes the National Cancer Database (NCDB) to examine the impact of demographics, clinical presentation, and treatment on the overall survival of patients diagnosed with ovarian carcinosarcoma. Methods: A cohort of 420 patients diagnosed with ovarian carcinosarcoma was identified in the NCDB from 2004 to 2020. Patient characteristics and management strategies were analyzed using Kaplan-Meier survival curves, log-rank tests, and multivariable Cox proportional hazard models to determine significance. Results: Advanced cancer stage was associated with increased mortality risk, as all stage comparisons yielded significant results, ranging from a nearly two-fold increase in risk comparing Stage I and Stage II cancers (HR: 1.96; 95% CI: 1.13−3.40; p = 0.017) to over a four-fold increase in Stage I vs. Stage IV hazard ratios (HR: 4.27; 95% CI: 2.64−6.90; p < 0.001). Likewise, increasing Charlson-Deyo comorbidity scores exhibited a trend towards higher mortality, although only the comparison of score 0 to scores ≥ 3 was statistically significant (HR: 6.70; 95% CI: 2.06−21.80; p = 0.002). Furthermore, only select comparisons within different income classes and educational attainment reached statistical significance. Treatment modalities were found to have inconsistent impacts on survival, as primary radiation therapy was associated with unfavorable survival outcomes (HR: 1.54; 95% CI: 1.00−2.37; p = 0.049), while chemotherapy significantly improved outcomes (HR: 0.40; 95% CI: 0.31−0.52; p < 0.001). When analyzed independently, surgical resection was not significantly associated with overall survival (HR: 0.95; 95% CI: 0.51−1.81; p = 0.887). Conclusion: Tumor staging, comorbidities, and certain treatment modalities were found to be significant predictive factors of ovarian carcinosarcoma survival. Comparisons between age, race, and insurance status were not significantly associated with overall survival.
Keywords: ovarian carcinosarcoma (OCS), National Cancer Database (NCDB), Demographics, Clinical presentation, Treatment, Overall survival (OS), gynecologic oncology
Received: 26 Jul 2025; Accepted: 04 Nov 2025.
Copyright: © 2025 Chang, Surendra, Hsia, Patel, Thirumalareddy and Tauseef. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Amber Chang, achang41@usf.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.